13 Sep 2022 --- A new clinical trial aims to perform a large-scale investigation on the impact of combining the oral anti-diabetic medication Empagliflozin with vitamins D3 and K2. The study will utilize the company’s naturally fermented vitamin K2 MK7 product to test the combination’s effect on the quality of life and a range of other diabetic parameters.
